Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong · Delayed Price · Currency is HKD 17.38
-0.27 (-1.53%)
Jul 31, 2026, 4:08 PM HKT
Sinopharm Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 36,366 | 48,796 | 54,313 | 63,809 | 55,222 | 43,529 |
Short-Term Investments | - | 2,758 | 3,172 | 3,330 | 3,199 | 2,812 |
Trading Asset Securities | 0.12 | 0.13 | 0.16 | 0.55 | 0.5 | 11.75 |
Cash & Short-Term Investments | 36,367 | 51,554 | 57,486 | 67,139 | 58,421 | 46,353 |
Cash Growth | -19.82% | -10.32% | -14.38% | 14.92% | 26.04% | -12.29% |
Accounts Receivable | 237,816 | 206,652 | 201,479 | 185,790 | 171,204 | 172,576 |
Other Receivables | 6,940 | 4,938 | 5,248 | 4,007 | 3,703 | 3,698 |
Receivables | 244,756 | 211,589 | 206,727 | 189,797 | 174,908 | 176,273 |
Inventory | 66,633 | 63,341 | 62,353 | 60,028 | 60,926 | 51,500 |
Restricted Cash | - | 1,354 | 1,328 | 1,850 | 1,488 | - |
Other Current Assets | 8,335 | 18,957 | 19,554 | 18,022 | 23,665 | 16,796 |
Total Current Assets | 356,091 | 346,796 | 347,448 | 336,835 | 319,406 | 290,922 |
Property, Plant & Equipment | 15,105 | 18,229 | 19,632 | 19,898 | 19,647 | 19,408 |
Long-Term Investments | 11,641 | 11,310 | 10,894 | 10,551 | 9,840 | 9,184 |
Goodwill | 5,735 | 5,784 | 6,252 | 7,186 | 7,156 | 7,199 |
Other Intangible Assets | 3,826 | 2,249 | 2,473 | 2,830 | 2,941 | 3,116 |
Long-Term Accounts Receivable | - | 896.7 | 1,156 | 793.92 | 1,123 | 874.58 |
Long-Term Deferred Tax Assets | 2,948 | 2,849 | 2,408 | 1,964 | 1,980 | 1,787 |
Long-Term Deferred Charges | 1,057 | 142.29 | 224.01 | 180.02 | 74.44 | 76.61 |
Other Long-Term Assets | 4,431 | 2,106 | 2,344 | 3,158 | 2,607 | 2,845 |
Total Assets | 400,835 | 390,361 | 392,831 | 383,395 | 364,775 | 335,412 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 150,804 | 150,248 | 151,109 | 146,632 | 137,085 | 128,431 |
Accrued Expenses | 1,373 | 7,547 | 8,123 | 8,832 | 9,571 | 8,354 |
Current Portion of Long-Term Debt | - | 63,321 | 62,729 | 54,730 | 52,997 | 55,152 |
Current Portion of Leases | - | 1,499 | 1,761 | 1,797 | 1,636 | 1,548 |
Current Income Taxes Payable | 1,880 | 1,412 | 1,447 | 1,775 | 1,703 | 1,614 |
Current Unearned Revenue | 6,359 | 5,984 | 6,829 | 6,399 | 10,396 | 6,086 |
Other Current Liabilities | 25,045 | 16,714 | 18,377 | 21,326 | 21,574 | 18,122 |
Total Current Liabilities | 254,708 | 246,726 | 250,376 | 241,491 | 234,963 | 219,307 |
Long-Term Debt | 4,041 | 3,645 | 8,637 | 13,834 | 11,750 | 8,419 |
Long-Term Leases | 2,467 | 2,495 | 3,259 | 3,421 | 3,207 | 3,250 |
Long-Term Unearned Revenue | 383.83 | 417.32 | 413.86 | 448.24 | 493.85 | 462.74 |
Pension & Post-Retirement Benefits | - | 364.9 | 412.88 | 366.51 | 380.71 | 387.7 |
Long-Term Deferred Tax Liabilities | 637.42 | 565.22 | 638.75 | 788.38 | 936.74 | 1,023 |
Other Long-Term Liabilities | 2,107 | 1,988 | 2,406 | 2,727 | 2,975 | 2,910 |
Total Liabilities | 264,344 | 256,201 | 266,144 | 263,076 | 254,706 | 235,758 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3,121 | 3,121 | 3,121 | 3,121 | 3,121 | 3,121 |
Additional Paid-In Capital | 20,477 | 24,641 | 24,641 | 24,641 | 24,641 | 24,641 |
Retained Earnings | 61,889 | 60,565 | 55,532 | 51,197 | 44,701 | 38,516 |
Treasury Stock | -3.84 | -3.84 | -3.84 | -3.84 | -3.84 | -3.84 |
Comprehensive Income & Other | 37.81 | -4,370 | -4,407 | -4,373 | -4,391 | -4,388 |
Total Common Equity | 85,520 | 83,953 | 78,884 | 74,582 | 68,069 | 61,886 |
Minority Interest | 50,970 | 50,206 | 47,804 | 45,737 | 42,001 | 37,768 |
Shareholders' Equity | 136,491 | 134,160 | 126,687 | 120,319 | 110,069 | 99,654 |
Total Liabilities & Equity | 400,835 | 390,361 | 392,831 | 383,395 | 364,775 | 335,412 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 75,756 | 70,960 | 76,386 | 73,782 | 69,590 | 68,368 |
Net Cash (Debt) | -39,389 | -19,407 | -18,900 | -6,643 | -11,169 | -22,016 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -12.58 | -6.22 | -6.06 | -2.13 | -3.58 | -7.05 |
Filing Date Shares Outstanding | 3,121 | 3,121 | 3,121 | 3,121 | 3,121 | 3,121 |
Total Common Shares Outstanding | 3,121 | 3,121 | 3,121 | 3,121 | 3,121 | 3,121 |
Working Capital | 101,382 | 100,070 | 97,072 | 95,344 | 84,443 | 71,616 |
Book Value Per Share | 27.40 | 26.90 | 25.28 | 23.90 | 21.81 | 19.83 |
Tangible Book Value | 75,959 | 75,921 | 70,159 | 64,566 | 57,972 | 51,571 |
Tangible Book Value Per Share | 24.34 | 24.33 | 22.48 | 20.69 | 18.58 | 16.53 |
Buildings | - | 14,234 | 13,752 | 12,997 | 12,907 | 12,127 |
Machinery | - | 11,198 | 10,728 | 10,099 | 9,169 | 8,412 |
Construction In Progress | - | 842.34 | 739.81 | 505.47 | 800.05 | 718.53 |